Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #3984 on Halozyme Therapeutics Inc (HALO)
DewDiligence
06/03/15 12:16 PM
#3986 RE: DFRAI #3984
Halo's Enhanze platform…is effectively competing with biosimilars from MNTA in a way...